María José Sá

Fernando Pessoa University — Portugal

Medicine · Health Sciences

49h-index8.8kcitations377works3.52yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Multiple Sclerosis Research Studies(122), Neuroscience and Neuropharmacology Research(69), Peripheral Neuropathies and Disorders(35), Memory and Neural Mechanisms(33), Polyomavirus and related diseases(23)

Publications372 total

Managing reactivation of multiple sclerosis during treatment with natalizumab
Multiple Sclerosis Journal·2025Open Access
A Case Report and Literature Review on oral Verruciform Xanthoma
NATIONAL BOARD OF EXAMINATIONS JOURNAL OF MEDICAL SCIENCES·2025Open Access
Vision-Related Quality of Life in Patients with Optic Neuropathy: Insights from a Portuguese Single Center Using the NEI-VFQ-25
Neurology International·2025Open Access
Cerebrospinal fluid catecholamines levels in Alzheimer’s disease, frontotemporal dementia, and normal controls
Neurodegenerative Disease Management·2025
Relationship between cerebrospinal fluid catecholamines levels and biomarkers of Alzheimer’s disease, inflammation and neuronal injury
Neurological Research·2025
Determinants and Warning Signs of Inpatient Falls and Fall-Related Injuries in Tertiary Hospitals, Chennai
International Journal of Advanced Research in Science Communication and Technology·2025Open Access
Magnetic Resonance Imaging in Multiple Sclerosis: An Analysis of the Implementation of the Portuguese Consensus
Acta Médica Portuguesa·2025· 1 citedOpen Access
Multiple sclerosis relapse incomplete recovery and associated factors – a systematic review and meta-analysis
Multiple Sclerosis and Related Disorders·2025· 2 citedOpen Access
PERSIMS: Comparing doctors and patients PERSpectives on quality of life In Multiple Sclerosis
Journal of Clinical Neuroscience·2025
Multiple Sclerosis Disease-Modifying Treatment Algorithms: 2025 Positioning of the Portuguese Multiple Sclerosis Study Group
Acta Médica Portuguesa·2025· 2 citedOpen Access
Portuguese Consensus for the Evaluation of the Multiple Sclerosis Treatment Response: A Delphi Panel
Sinapse·2025Open Access
A0793 – Translational correlates using urinary genomic disease burden to assess cretostimogene grenadenorepvec: Analysis from the BOND-003 and CORE-001 trials
European Urology·2025
Longitudinal Study of Cognitive Phenotypes in Patients with Relapsing–Remitting Multiple Sclerosis
Archives of Clinical Neuropsychology·2025· 1 cited
First-year treatment response predicts the following 5-year disease course in patients with relapsing-remitting multiple sclerosis
Neurotherapeutics·2025· 5 citedOpen Access
Treatment De-escalation in Relapsing-Remitting Multiple Sclerosis: An Observational Study
CNS Drugs·2025· 6 citedOpen Access
Stroke prevention in Hispanic children with sickle cell anemia: the SACRED trial
Blood Advances·2025· 4 citedOpen Access
Epidermolytic Hyperkeratosis in a Resource-Limited Setting: A Case Report from Yemen
2025
Clinical and analytical monitoring of patients with multiple sclerosis on anti-CD20 therapeutics: a real-world safety profile study
Frontiers in Neurology·2025· 7 citedOpen Access
Prevalence, uses and factors affecting Psychoactive Substance Use among undergraduates in a Nigerian University
African Research Journal of Medical Sciences·2025Open Access
Assessing the contribution of rADAMTS13 to the treatment of congenital thrombotic thrombocytopenic purpura in Spain using Multi-Criteria Decision Analysis (MCDA)
Economía de la Salud·2025Open Access
page 1 of 19Next →

Frequent Co-authors

M. Dulce Madeira(24), Nuno Sousa(10), Maria Amélia Ferreira(8), A. Cadete‐Leite(7), Nikolay Lukoyanov(6), José Paulo Andrade(6), Osborne F. X. Almeida(4), Vincent Van Pesch(4), Raed Alroughani(3), A. R. Lieberman(3), Cavit Boz(3), Helmut Butzkueven(3), Dana Horáková(3), Pierre Grammond(3), Joana Guimarães(2), Thomas Berger(2), Magd Zakaria(2), C. Ruela(2), Peter Vestergaard Rasmussen(2), Anneke van der Walt(2)